Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-29 09:30:01 - browse：9

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

leisure time

WSS

STAT Summit: Meghan O’Rourke on making chronic illness visible

Obesity drug from Roche shows promise in early study

STAT Summit: Meghan O’Rourke on making chronic illness visible

STAT series 'Denied by AI' wins major journalism prizes

FDA clears Verve to begin U.S. study of gene

STAT Readout: Friday, Oct. 20 biotech updates

focus

Wikipedia

focus

In Memoriam: Notable people who died in 2023

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Trump demands the U.S. pay no more for drugs than other countries … again

Supreme Court to hear if Covid misinformation is protected speech

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The United States must get value

Continuity nursing helped my family in our darkest PICU moments

CZI to create biohub to build anti

Trump demands the U.S. pay no more for drugs than other countries … again

Cherokee Nation medical school graduates its first class

Wikipedia

How AI can help patients find reliable information about doctors

Novo Nordisk testing Wegovy against alcohol

ALS treatment from Biogen, Ionis fails in study

ADCs take center stage as promising cancer treatments

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Summit: The economic case for universal basic health care

entertainment

entertainment

leisure time

leisure time